Preclinical Assessment Addressing Intravenous Administration of a [<sup>68</sup>Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
It has been herein presented that a microemulsion, known to be an effective and safe drug delivery system following intravenous administration, can be loaded with traces of [<sup>68</sup>Ga]Ga-PSMA-617 without losing its properties or causing toxicity. Following tolerated IV injections t...
Main Authors: | Vusani Mandiwana, Lonji Kalombo, Rose Hayeshi, Jan Rijn Zeevaart, Thomas Ebenhan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/9/2650 |
Similar Items
-
A Simple Kit for the Good-Manufacturing-Practice Production of [<sup>68</sup>Ga]Ga-EDTA
by: Monika Skulska, et al.
Published: (2023-08-01) -
<sup>68</sup>Ga-DOTATATE and <sup>68</sup>Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum
by: Rui Zuo, et al.
Published: (2024-02-01) -
Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [<sup>68</sup>Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [<sup>68</sup>Ga]Ga-PSMA-11
by: René Fernández, et al.
Published: (2023-12-01) -
Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021-04-01) -
Analysis of Pros and Cons in Using [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007: Production, Costs, and PET/CT Applications in Patients with Prostate Cancer
by: Costantina Maisto, et al.
Published: (2022-06-01)